PPARG and metabolic disease: Recent evidence shows that the modulation of Pparγ phosphorylation events (S273) protect against insulin resistance [11,12], indicating that the selective regulation of Pparγ can provide new strategies against metabolic diseases, including diabetes, without deleterious effects [13].